105.09
price down icon0.05%   -0.05
after-market After Hours: 105.14 0.05 +0.05%
loading
Verona Pharma Plc Adr stock is traded at $105.09, with a volume of 2.19M. It is down -0.05% in the last 24 hours and up +11.11% over the past month. Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
See More
Previous Close:
$105.14
Open:
$105.15
24h Volume:
2.19M
Relative Volume:
0.65
Market Cap:
$8.95B
Revenue:
-
Net Income/Loss:
$-153.72M
P/E Ratio:
-52.55
EPS:
-2
Net Cash Flow:
$-103.81M
1W Performance:
+0.09%
1M Performance:
+11.11%
6M Performance:
+83.40%
1Y Performance:
+363.77%
1-Day Range:
Value
$105.06
$105.24
1-Week Range:
Value
$104.97
$105.50
52-Week Range:
Value
$18.51
$105.50

Verona Pharma Plc Adr Stock (VRNA) Company Profile

Name
Name
Verona Pharma Plc Adr
Name
Phone
011-44-0-2032834200
Name
Address
3 MORE LONDON RIVERSIDE, LONDON
Name
Employee
209
Name
Twitter
@VeronaPharma
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
VRNA's Discussions on Twitter

Compare VRNA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
VRNA
Verona Pharma Plc Adr
105.09 8.95B 0 -153.72M -103.81M -2.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.87 120.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.46 59.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
392.24 44.31B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
670.33 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
301.13 32.46B 3.81B -644.79M -669.77M -6.24

Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-14-25 Downgrade H.C. Wainwright Buy → Neutral
Jul-01-25 Initiated Wolfe Research Outperform
Apr-28-25 Initiated TD Cowen Buy
Apr-21-25 Initiated Cantor Fitzgerald Overweight
Jan-10-25 Initiated ROTH MKM Buy
Oct-03-24 Initiated Wells Fargo Overweight
May-22-23 Resumed Jefferies Buy
Sep-19-22 Resumed Wedbush Outperform
Aug-26-22 Initiated Piper Sandler Overweight
Sep-13-21 Initiated H.C. Wainwright Buy
Aug-25-20 Initiated Jefferies Buy
Aug-10-20 Initiated Canaccord Genuity Buy
Apr-18-19 Initiated BTIG Research Buy
View All

Verona Pharma Plc Adr Stock (VRNA) Latest News

pulisher
Jul 29, 2025

Merck Q2: EPS Beats, but Sales Flat as Vaccine Demand Slips Globally - Investing.com

Jul 29, 2025
pulisher
Jul 25, 2025

Verona Pharma stock hits all-time high at 105.31 USD By Investing.com - Investing.com Nigeria

Jul 25, 2025
pulisher
Jul 25, 2025

Verona Pharma stock hits all-time high at 105.31 USD - Investing.com

Jul 25, 2025
pulisher
Jul 23, 2025

Verona Pharma Plc ADR’s Shares Reel: 69.24% Quarterly Revenue Decline Amid 8.93B Market Cap - investchronicle.com

Jul 23, 2025
pulisher
Jul 18, 2025

Verona Pharma stock reaches all-time high at 105.0 USD By Investing.com - Investing.com India

Jul 18, 2025
pulisher
Jul 18, 2025

Verona Pharma stock reaches all-time high at 105.0 USD - Investing.com Australia

Jul 18, 2025
pulisher
Jul 14, 2025

Merck to Acquire Verona Pharma in $10 Billion Deal to Expand Respiratory Drug Portfolio - MSN

Jul 14, 2025
pulisher
Jul 14, 2025

Pharmaceutical Stocks To Research – July 12th - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Top Medical Stocks To Follow Now – July 12th - Defense World

Jul 14, 2025
pulisher
Jul 11, 2025

Wells Fargo Downgrades Verona Pharma plcDepositary Receipt () (VRNA) - MSN

Jul 11, 2025
pulisher
Jul 10, 2025

Merck stock rises as UBS reiterates Buy rating after Verona Pharma acquisition By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 10, 2025

Merck to acquire Verona Pharma stock for $107 per ADS in $10 billion deal By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 10, 2025

Verona Pharma stock rating downgraded to Neutral by Roth/MKM after Merck offer - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 10, 2025

Merck to Acquire Verona Pharma for $10 Billion in Bid to Cushion "Patent Cliff" Impact - Mitrade

Jul 10, 2025
pulisher
Jul 10, 2025

Verona Pharma stock hits all-time high at 104.83 USD By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 09, 2025

American pharmaceutical company Merck acquires British Verona Pharma for $10 billion - AKM.RU

Jul 09, 2025
pulisher
Jul 09, 2025

Verona Pharma stock hits all-time high at 104.83 USD - Investing.com

Jul 09, 2025
pulisher
Jul 09, 2025

Verona Pharma Stock Jumps 20% on $10B Buyout Offer From Merck - Nasdaq

Jul 09, 2025
pulisher
Jul 09, 2025

Merck to acquire Verona Pharma for $10 billion By Investing.com - Investing.com Nigeria

Jul 09, 2025
pulisher
Jul 09, 2025

Merck dives into COPD treatments with $10 billion purchase of Verona Pharma - MarketWatch

Jul 09, 2025
pulisher
Jul 09, 2025

Merck to acquire Verona Pharma for $10 billion - Investing.com Australia

Jul 09, 2025
pulisher
Jul 09, 2025

Can Verona Pharma Plc ADR Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Jul 09, 2025
pulisher
Jul 09, 2025

Starbucks, Freeport-McMoran and Verona Pharma rise premarket; WPP, T-Mobile fall By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 09, 2025

Merck compra por 10.000 millones de dólares Verona Pharma - Yahoo Finanzas

Jul 09, 2025
pulisher
Jul 07, 2025

Best Momentum Stock To Buy For July 7th - Barchart.com

Jul 07, 2025
pulisher
Jul 02, 2025

Apellis Stock Rises on $300M Royalty Deal With Sobi for Aspaveli - Yahoo Finance

Jul 02, 2025
pulisher
Jun 24, 2025

Up 515%, Watch This Biopharma Breakout - inkl

Jun 24, 2025
pulisher
Jun 10, 2025

Verona Pharma: A Blockbuster Franchise In The Making - Seeking Alpha

Jun 10, 2025
pulisher
Jun 05, 2025

Investing $15,000 Into Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth $1 Million Today - Barchart.com

Jun 05, 2025
pulisher
Jun 05, 2025

Piper Sandler reiterates Verona Pharma stock rating and target By Investing.com - Investing.com UK

Jun 05, 2025
pulisher
Jun 02, 2025

21 Best-Performing Small-Cap Stocks for June 2025 - NerdWallet

Jun 02, 2025
pulisher
May 30, 2025

Verona Pharma (VRNA) Shares Soar 5.47% to Record High - AInvest

May 30, 2025
pulisher
May 29, 2025

Verona Pharma ADR Surges, Matches Key 52-Week High: What’s Fueling the Rally? - Daily Chhattisgarh News

May 29, 2025
pulisher
May 29, 2025

Verona Pharma stock soars to all-time high of $77.08 By Investing.com - Investing.com Nigeria

May 29, 2025
pulisher
May 23, 2025

FDA Approves GSK's Nucala for Expanded Use in COPD - Zacks Investment Research

May 23, 2025
pulisher
May 20, 2025

Restart of Student Loan Repayments Could Squeeze Consumer Spending and Slow Economic Growth - iHeart

May 20, 2025
pulisher
May 20, 2025

Verona Pharma stock soars to all-time high of $74.36 By Investing.com - Investing.com UK

May 20, 2025
pulisher
May 08, 2025

Market Update: Verona Pharma Plc ADR (VRNA) Sees Negative Movement, Closing at 69.14 - DWinneX

May 08, 2025
pulisher
May 08, 2025

Verona Pharma Plc ADR (NASDAQ: VRNA): An Enticing Stock To Watch - Stocksregister

May 08, 2025
pulisher
May 06, 2025

IBD Stock Of The Day Verona Pharma Tests Buy Point After Earnings Breakout - Investor's Business Daily

May 06, 2025
pulisher
May 01, 2025

Verona Pharma’s general counsel sells shares worth $234,126 By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

Verona Pharma director Vikas Sinha sells $178,416 in stock By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Verona Pharma’s general counsel sells shares worth $234,126 - Investing.com

May 01, 2025
pulisher
May 01, 2025

Verona Pharma Plc ADR (VRNA)’s Market Momentum: Closing Strong at 72.07, Down -1.56 - DWinneX

May 01, 2025
pulisher
Apr 30, 2025

What is Verona Pharma Plc ADR (VRNA) Stock Return on Shareholders’ Capital? - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Verona Pharma Plc ADR [VRNA] Stock trading around $73.21 per share: What’s Next? - dbtnews.com

Apr 30, 2025
pulisher
Apr 29, 2025

VRNA’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Apr 29, 2025
pulisher
Apr 29, 2025

Watch this stock’s price performance: Verona Pharma Plc ADR (NASDAQ:VRNA) - uspostnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Verona Pharma ADR earnings beat by $0.05, revenue topped estimates - Investing.com UK

Apr 29, 2025
pulisher
Apr 28, 2025

Verona Pharma Plc ADR (NASDAQ: VRNA) Could Soar To Much Higher Prices In Coming Months - Marketing Sentinel

Apr 28, 2025
pulisher
Apr 28, 2025

TD Cowen starts Verona Pharma stock at Buy, sets $100 target - Investing.com

Apr 28, 2025

Verona Pharma Plc Adr Stock (VRNA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$74.89
price down icon 3.43%
$36.80
price down icon 0.86%
$107.28
price up icon 2.00%
$26.37
price down icon 1.09%
$107.50
price down icon 2.32%
biotechnology ONC
$301.13
price up icon 0.40%
Cap:     |  Volume (24h):